Xeris Biopharma Holdings Accounts Receivable (Quarterly) Insights

Xeris Biopharma Holdings Inc (XERS)

2.105 -0.02 (-0.71%) USD | NASDAQ | Jun 25, 16:00

2.105 0.00 (0.00%) After-Hours: 20:00

Accounts Receivable (Quarterly) Chart

Historical Accounts Receivable (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	37.41M
December 31, 2023	39.20M
September 30, 2023	45.97M
June 30, 2023	30.22M
March 31, 2023	30.86M
December 31, 2022	30.83M
September 30, 2022	27.52M
June 30, 2022	25.76M
March 31, 2022	23.38M
December 31, 2021	17.46M
September 30, 2021	13.56M
June 30, 2021	12.30M
March 31, 2021	8.938M

Date	Value
December 31, 2020	6.875M
September 30, 2020	11.93M
June 30, 2020	3.171M
March 31, 2020	2.531M
December 31, 2019	4.693M
September 30, 2019	0.874M
June 30, 2019	0.826M
March 31, 2019	3.628M
December 31, 2018	0.00
September 30, 2018	1.731M
June 30, 2018	1.065M
March 31, 2018	0.287M
December 31, 2017	1.199M

Accounts Receivable Definition

Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.

Read full definition.

Accounts Receivable (Quarterly) Range, Past 5 Years

0.826M

Minimum

Jun 2019

45.97M

Maximum

Sep 2023

18.71M

Average

15.51M

Median

Accounts Receivable (Quarterly) Benchmarks